2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE The biomarker field is advancing quickly, and aside from mass biomarker arrays analyzed by AI, single biomarkers have been established to help in predicting disease course and monitoring response to therapy. The role of NfL is by far the most advanced in aligning with …
Continue reading “Emerging and Established Biomarkers in Neuroinflammatory Disease”
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE This session will address common challenges in the pharmacological management of neuroimmunological conditions. The discussion will begin with special populations, including pregnant and lactating women and older adults. These life stages are characterized by the potential for spontaneous remission of …
2026 Charlotte, NC sessions AAPA, ACPE, APA, ASWB, CME, Letter of Completion, NCPD, IPCE This symposium will provide updates on current topics of interest in the MS community. Each topic will be presented with ample time for questions/discussion. Level of Information: Basic, Intermediate, Advanced Patricia K. Coyle , MD
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Spinal cord disease is important in most people with MS , but is less emphasized in patient care, basic, clinical research, and therapeutic trials. Clinically relevant spinal cord disease in MS is crucial to recognize. How and when to image the spinal cord …
Continue reading “Spinal Cord in MS: Key Clinical and Imaging Considerations”
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Part 1: Pediatric Onset MS patients are more likely to have higher disease activity and may experience two to three times as many clinical attacks as adults. The onset of MS during a developmental period in which myelination is …
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This session will introduce participants to the biologic and clinical basics of rare neuroimmune conditions such as neuromyelitis optic, anti-MOG associated disorder, autoimmune encephalitis, myelitis, neurosarcoidosis and stiff person syndrome. Participants will be educated about diagnostic criteria and appropriate …
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Infections are associated with most MS disease modifying therapies, but the risks and related management strategies vary considerably. Our faculty of MS neurologists and advanced practice providers will review 1) what therapies have what infection risks, including rare infection risks; 2) risk factors …
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE This hands-on workshop is designed to transition participants from theoretical knowledge to clinical application, covering both upper and lower extremities. • Didactic Sessions: Participants will learn the mechanisms of action, therapeutic indications for MS-related spasticity, goal setting (e.g., using Goal Attainment Scaling), and patient …
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Nature continues to show that our own body can produce cells that can modify and treat a variety of conditions, including autoimmune diseases like MS. Technology allows for the isolation, purification and modification of cells to exploit their various properties. In this session …
Continue reading “Emerging Cell-based Therapies in Multiple Sclerosis”
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE There has been an explosion of new MS disease modifying therapies over the last decade. These therapies offer people with MS many treatment options including different routes of administration and mechanisms of action. With so many treatment options, selecting the right therapy for …
Continue reading “Era of Too Many Choices; Starting and Switching”